The global glycine sector is on track to achieve a valuation of USD 2.7 billion by 2036, accelerating from USD 1.5 billion in 2026 at a CAGR of 6.8%. As per Future Market Insights, expansion is structurally underpinned by growing demand across pharmaceutical excipients, food flavoring, animal nutrition, and personal care formulations where glycine's multifunctional properties as a pH buffer, sweetener, and chelating agent make it indispensable. The International Federation of Pharmaceutical Manufacturers (IFPMA) has highlighted the increasing use of amino acid excipients in biologics and biosimilar formulations, validating glycine's role in the fastest-growing segment of the pharmaceutical industry. This demand trajectory compels glycine producers to expand pharmaceutical-grade capacity. Simultaneously, the supply landscape is undergoing structural change as Western producers exit or restructure while Chinese capacity continues to expand.
In June 2024, GEO Specialty Chemicals ceased operations at its Allentown, Pennsylvania, facility, significantly impacting the domestic U.S. supply chain for technical and industrial-grade glycine. In October 2024, Evonik announced a strategic restructuring of its keto and pharma amino acid business, which includes its glycine portfolio, as part of its Next Generation Evonik strategy to focus on high-growth specialty chemicals. FMI opines that the concurrent exit of GEO from U.S. glycine production and Evonik's restructuring of its amino acid business are concentrating Western pharmaceutical-grade glycine supply in fewer hands, creating pricing power for remaining producers and procurement risk for buyers dependent on non-Chinese sources.
The operational reality for glycine suppliers is defined by the need to balance the growing demand from high-margin pharmaceutical and personal care applications with the commodity pricing pressure from food-grade and industrial segments. In September 2024, Ajinomoto and Danone formed a global alliance leveraging Ajinomoto's AjiPro L amino acid absorption technology to reduce emissions in the dairy supply chain, representing a strategic pivot in animal nutrition where glycine-based amino acid supplementation is being repositioned as a sustainability tool. As per FMI, the glycine market is entering a phase where pharmaceutical-grade and food-grade segments are diverging in both pricing and supply chain requirements. FMI is of the opinion that buyers of pharma-grade glycine will increasingly seek long-term supply agreements with qualified producers to insulate against the supply concentration risk created by Western capacity exits.
Future Market Insights projects the glycine market to expand at a CAGR of 6.8% from 2026 to 2036, increasing from USD 1.5 Billion in 2026 to USD 2.7 Billion by 2036.
FMI Research Approach: FMI proprietary forecasting model based on pharmaceutical excipient demand and amino acid production capacity data.
FMI analysts perceive the market evolving toward a bifurcated structure where pharmaceutical-grade glycine commands premium pricing under long-term supply agreements, while food and industrial grades face commodity pricing from concentrated Chinese production.
FMI Research Approach: GEO Specialty Chemicals Allentown exit (June 2024) and Evonik amino acid restructuring (October 2024).
China holds a significant share, supported by the world's largest glycine production capacity and the lowest cost of manufacturing through established chemical synthesis and fermentation infrastructure.
FMI Research Approach: FMI country-level revenue modeling by glycine production capacity and trade flow data.
The global glycine market is projected to reach USD 2.7 Billion by 2036.
FMI Research Approach: FMI long-term forecast from pharmaceutical excipient demand projections and animal nutrition amino acid supplementation trends.
The glycine market includes revenue from the production and sale of glycine (aminoacetic acid) across pharmaceutical, food-grade, technical, and feed-grade applications used in drug formulations, food flavoring, personal care, and animal nutrition.
FMI Research Approach: FMI market taxonomy aligned with pharmacopoeia grade classifications.
Trends include Western production capacity exits concentrating supply in China, pharmaceutical-grade premiumization under long-term agreements, and amino acid repositioning as sustainability tools in animal nutrition.
FMI Research Approach: GEO exit (June 2024), Evonik restructuring (October 2024), and Ajinomoto-Danone alliance (September 2024).
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 1.5 Billion |
| Industry Value (2036) | USD 2.7 Billion |
| CAGR (2026 to 2036) | 6.8% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research
Glycine prices vary depending on production costs, raw materials availability, and the level of purification required. In the USA, prices are higher due to strict regulatory requirements and the use of advanced manufacturing technologies for high-purity grades, specifically for pharmaceutical and food applications.
| Countries | Price (USD/kg) |
|---|---|
| United States | 4.00 - 5.50 |
| India | 2.50 - 3.50 |
| China | 2.00 - 3.00 |
| United Kingdom | 4.50 - 6.00 |
| Germany | 4.00 - 5.00 |
In the UK, glycine is an expensive commodity available at USD 4.50 to 6.00 per kg. The scenario here centers around high-quality, food-grade, and pharmaceutical-grade glycine, which requires higher production and compliance standards.
Germany is also expected to follow a similar trend and follow a price range of USD 4.00 to 5.00 per kg in 2025, considering the demand for glycine in the food, agriculture, and pharmaceutical industries. Therefore, the glycine prices can vary between regions because of local demand, manufacturing capability, and regulations.
The glycine trade is an interesting dynamic in terms of each country's production capacities and market needs. The USA is a large exporter of glycine, accounting for approximately 14,000 MT annually..
This balanced trade scenario shows that the USA has a large manufacturing base, specifically for pharmaceutical-grade Glycine, and exports high-quality glycine products to meet global demands. However, imports remain indispensable for specific demand segments in the application areas including food, cosmetics, and medicine.
India has maintained a positive export-import balance in the past few years. Glycine finds a ready market in Southeast Asia and neighboring countries where its pharmaceutical and agrochemical markets are rapidly growing.
| Countries | Export/Import Volume (Metric Tons) (2026) |
|---|---|
| United States | Export: 14,000 MT, Import: 12,000 MT |
| India | Export: 10,000 MT, Import: 8,500 MT |
| China | Export: 18,000 MT, Import: 5,000 MT |
| United Kingdom | Export: 4,500 MT, Import: 4,000 MT |
| Germany | Export: 7,800 MT, Import: 6,000 MT |
China is the world’s largest producer and exporter of glycine is projected to lead with 18000 MT in exports and 5,000 MT imports roughly in 2025. Its exports are highly voluminous because of its cheap production cost, which targets industrial applications, including agrochemicals and animal feed.
Germany is projected to roughly export 7,800 MT and import worth 6,000 MT in 2025. Meanwhile, the UK exports 4,500 MT and imports 4,000 MT annually. Both are among the key contributors in the European market for glycine and their demand comes mainly from the pharmaceuticals, food and agricultural sectors.
Growing Demand in Pharmaceuticals and Healthcare
The use of glycine has greatly increased in the pharmaceutical and healthcare sectors. Glycine is an essential amino acid used to synthesize proteins, and is used in formulating many medicines. It plays a vital role in treating central nervous system disorders including schizophrenia and is used as a therapeutic agent in various neurological treatments.
Moreover, glycine is used as a nutraceutical supplement because it can help support the production of collagen, muscle health and promote general well-being thereby contributing to the growing demand in healthcare products.
Increasing Use in the Food and Beverage Industry
Another significant driver is the rise in use of Glycine as a flavor enhancer and sweetener in the food and beverage industry for a variety of food products, such as processed foods, soft drinks, and confectionery items.
It has a mild sweetness and masks bitterness. It is an ideal ingredient to formulate food and beverage products. As consumer preferences shift towards more processed food options and advanced flavor combinations, the demand for glycine in this sector continues to rise further boosting the market.
Environmental Concerns Related to Production Processes
Glycine manufacturing, mainly follows the conventional chemical synthesis process, often produces toxic waste byproducts including hydrogen chloride that must be handled and treated. Strict regulatory controls and associated increased waste handling and treatment costs tend to constrain growth in glycine production capacity and hence affect market expansion. The industry also depends on raw material availability and price fluctuations, which may further create challenges.
The glycine market is witnessing notable growth with applications growing in the nutraceutical and pharmaceutical industries. In the nutraceutical sector, dietary supplements containing glycine are widely used for its function in protein synthesis, thus promoting a better sleep quality in consumers.
In the pharmaceutical segment, the demand is rising with glycine being prescribed for muscle spasms, and stomach upsets, and even used as an ingredient in intravenous solutions.
Additionally, another key trend is the growing uptake of glycine in animal feed and agrochemicals. Its inclusion in animal feed supports the rise and improves the overall health of livestock, addressing the needs of the global meat and poultry industry.
The mega-consumer trend in consumer market is the increasing demand for wellness and health-oriented products. Consumers emphasize functional ingredients that provide both nutritional and therapeutic benefits.
Glycine plays an important role in supporting protein synthesis, enhancing sleep quality, improving joint health, and promoting overall cellular function, making it a sought-after ingredient for health-conscious individuals.
Moreover, it has also been fuelled by the rise of personalization in nutrition where glycine is designed for certain applications and has a niche within health products promoting better recovery, stress reduction, or gut health.
| Attributes | Details |
|---|---|
| Top Grade | Technical Grade |
| Market Share in 2026 | 38.5% |
Based on grade, the market is divided into food grade, technical grade, and pharma grade. The technical grade segment is expected to account for 38.5% market share in 2026. Technical-grade glycine witness a huge demand because it is cheaper and is versatile for industrial applications.
Food-grade or pharmaceutical-grade glycine on the other hand demands higher purity standards. Technical-grade glycine, however, satisfies the functional requirements for agrochemicals, animal feed, and industrial processes without added costs of high-purity production. This makes it an economical choice for manufacturers in these sectors.
Additionally, technical-grade glycine plays a significant role in the production of herbicides including glyphosate, where its functional properties are essential but do not demand the higher purity levels for consumable products.
| Attributes | Details |
|---|---|
| Top End-Use Industry | Food & Beverage Industry |
| Market Share in 2026 | 45.2% |
Based on the end-use industry, the market is divided into the food & beverage, pesticides, pharmaceuticals, cosmetics, feed, and dietary supplements industry. The food & pharmaceuticals industry is expected to account for 45.2% market share in 2026.
The growing usage of the multifunctional property and clean-label compatibility is pushing the glycine amino acid into growing applications in the food and beverages sector.
Since glycine is an amino acid that is naturally found, it serves as a flavor enhancer that brings out the sweet and balances the salty or bitter flavor in several products. This increases the uptake by manufacturers of decreasing sugar content or artificial flavoring additives without loss of taste.
Indian market is poised to grow at a CAGR of 8.5% by 2036, mainly due to the country's increasing industrial and consumer sectors. Glycine is used for pharmaceutical purposes, mainly as a drug manufacturing component and as an excipient in many formulations. As one of the global pharmaceutical manufacturing hubs, India has witnessed increased domestic and export demand for medicines.
The China glycine industry is the largest global. The country's comprehensive industrial and manufacturing sectors drive the industry forward. As one of the major markets for pharmaceutical, food, and cosmetic uses, demand for Glycine is skyrocketing in China. Another reason driving demand has been the food and beverage sector, which uses it as a flavor enhancer and preservative.
Moreover, the growing pharmaceutical industry has increased the use of Glycine in amino acid supplements and drugs. China is expected to take the lion's share of the market by 2035 and will continue to promote growth with further innovations in biotechnology and increased consumer demand for natural and functional ingredients.
The UK is expected to witness steady growth owing to its general application in the pharmaceutical and food industry. The focus of the health and wellness industry in the UK creates a demand for glycine products, primarily through dietary supplements and functional foods.
Additionally, Glycine is used in moisturizing applications and anti-aging products in the personal care and cosmetic business. Natural glycine applications in the UK are increasingly gaining momentum with a strong focus on sustainability and clean-label products.
The pharmaceuticals, cosmetics, and food industries need Glycine predominantly in Germany, one of the largest markets in Europe for wellness and health goods.
Amino acid-based nutrition supplements, food additives, and personal care formulations are applications of Glycine in Germany with growing demand.
Due to the increased consciousness of consumers concerning the use of natural and organic ingredients in the food and cosmetics sectors, the industry is witnessing positive growth. Germany's share is expected to continue steadily upward till 2035, with growing interest in Glycine's functional properties and applications.
The demand for amino acids in pharmaceuticals, personal care, and food industries is driving the growth of Spain's glycine market. The country is increasingly focusing on health-conscious consumers and natural, clean-label products, which is driving the use of Glycine, especially in dietary supplements, functional foods, and cosmetics. The demand for Glycine as a building block for collagen synthesis and skincare applications is also increasing in Spain's skincare industry.
USA is expanding to grow at a positive CAGR in the forecast period because of the robust demand in various sectors, including pharmaceuticals, food and beverages, and agriculture. Glycine is extensively used as an excipient in drug formulations and intravenous solutions in the pharmaceutical industry.
The increasing prevalence of chronic diseases and innovation in healthcare technologies in the USA has led to a rise in demand for amino acids such as glycine medical applications. The food and beverage industry in the USA is another significant driver, as Glycine is used as a flavor enhancer, preservative, and protein supplement.
A mixed pool of international and regional companies competes for a more potent global market grip. The leaders among the key players in this market include Ajinomoto Co., Inc., Evonik Industries AG, Chattem Chemicals, Inc., and Shijiazhuang Donghua Jinlong Chemical Co., Ltd.
Other major players aim to expand production capacity to ensure constant supply, mainly to the pharmaceutical, nutraceutical, and agrochemical markets. For example, Ajinomoto, through its fermentation-based technologies, aims to achieve high-purity glycine manufacturing aligned with sustainability trends.
Additionally, growth strategies also include advancement and diversification to meet the changing needs of customers. Many companies are investing in research and development to explore bio-based and environment-friendly glycine production methods.
Recent Developments
The glycine market represents revenue from the production and sale of glycine across pharmaceutical excipient, food and beverage flavoring, animal nutrition, and personal care applications.
Inclusions cover pharmaceutical-grade glycine (USP, EP), food-grade glycine, technical-grade glycine for industrial chelation, and feed-grade glycine for animal nutrition. All synthesis routes (Strecker, chloroacetic acid, enzymatic) are included.
Exclusions include glycine derivatives (N-methylglycine, glycine betaine) classified under separate markets, and glycine produced solely for internal captive consumption within integrated chemical complexes.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 1.5 Billion |
| Grade | Pharmaceutical, Food, Technical, Feed |
| Application | Pharmaceutical Excipients, Food Flavoring, Animal Nutrition, Personal Care |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Key Companies Profiled | Ajinomoto, Evonik, Chattem Chemicals, Yuki Gosei Kogyo, Showa Denko |
In terms of grade, the glycine market is segmented into food grade, technical grade, and pharma grade.
In terms of the end-use industry, the market is segmented into the food & beverage, pesticides, pharmaceuticals, feed, cosmetics, and dietary supplements industry.
In terms of region, the market is segmented into North America, Europe, Asia Pacific, and Middle-East and Africa.
What is the current global market size for Glycine?
The global market is valued at USD 1.5 Billion in 2026, driven by growing pharmaceutical excipient demand in biologics formulations and the multifunctional use of glycine across food, personal care, and animal nutrition.
What is the projected Compound Annual Growth Rate (CAGR) for the market over the next 10 years?
The market is projected to grow at a CAGR of 6.8% from 2026 to 2036.
Which regions are experiencing the fastest expansion?
Asia Pacific leads driven by China's dominant production capacity and India's expanding pharmaceutical and food processing sectors, with India projected to grow at 10.3% CAGR.
What are the primary market drivers?
Pharmaceutical excipient demand growth in biologics formulations and the supply chain restructuring concentrating Western glycine capacity are the primary forces driving both volume growth and pricing premiums.
Who are the leading suppliers in the industry?
Ajinomoto, Evonik, Chattem Chemicals, Yuki Gosei Kogyo, and Showa Denko are key players, differentiating through pharmacopoeia-grade certifications, fermentation-based production, and long-term pharmaceutical supply agreements.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Glycine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
